非侵襲的がん診断の世界市場 - 市場規模：技術別、機器別、地域別、予測

非侵襲的がん診断の市場規模と予測

非侵襲的がん診断の市場規模は、ここ数年かなりの成長率で緩やかなペースで成長しており、市場推計・予測期間（i.e. 2026年から2032年）には大きく成長すると予測されます。

大規模な都市化、人々の消費力の増加、がん診断における最新の技術的進歩や動向に関するより多くの認識、非侵襲的がん診断の利点が、まもなくこの市場の成長につながります。非侵襲的がん診断の世界市場レポートは、市場の全体的な評価を提供します。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界の非侵襲的がん診断市場の定義

非侵襲的がん診断とは、針を使わない診断技術でがん疾患を特定または測定するプロセスです。この診断法には、バイオマーカー、分子生物学的変化、遺伝子構造、その他の画像診断技術など、いくつかの技術が含まれます。バイオテクノロジー分野の開発により、がんの早期発見のための非侵襲的がん診断の開発が可能になりました。

非侵襲的がん診断の世界市場概要

市場成長を促進する主な要因は、非侵襲的がん診断が、体内の最小限の切開でがんの問題を特定する方法であることです。このプロセスは一般に、遺伝子構造の同定、バイオマーカー、分子生物学的改変、画像化技術など、さまざまな技術で構成されます。正確で侵襲の少ない診断に対する需要の高まりと医療費の増加は、重要な促進要因として世界中で観察されています。

さらに、非侵襲的診断に対する需要の高まりは、医療インフラを改善するための政府のイニシアチブを増加させ、研究開発プロジェクトの増加も市場開拓の原動力となっています。しかし、高い治療費と厳しい規制ガイドラインが市場成長の妨げとなっています。機器の急速な技術進歩やイノベーションは、市場に有益な機会をもたらすと期待されています。一方、未開拓の新興諸国のニーズが市場成長の課題となる可能性もあります。

目次

第1章 世界の非侵襲的がん診断市場のイントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界の非侵襲的がん診断市場の展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 非侵襲的がん診断の世界市場：技術別

• 概要
• 臨床化学
• 免疫化学
• 分子診断

第6章 非侵襲的がん診断の世界市場：機器別

• 概要
• 固形がん
• 血液がん
• 肺がん
• 乳がん

第7章 非侵襲的がん診断の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 世界の非侵襲的がん診断市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第9章 企業プロファイル

• Precision Therapeutics, Inc.
• AVIVA Biosciences Corporation
• Affymetrix Inc.
• BIOVIEW Inc.
• Gen-Probe Incorporated

第10章 付録

• 関連調査

Non-Invasive Cancer Diagnosis Market Size And Forecast

Non-Invasive Cancer Diagnosis Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2026 to 2032.

Large-scale urbanization, an increase in the spending power of people, more awareness about the latest technological advancements and trends in cancer diagnosis, and the benefits of non-invasive cancer diagnosis will lead to the growth of this market shortly. The Global Non-Invasive Cancer Diagnosis Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Non-Invasive Cancer Diagnosis Market Definition

A non-Invasive cancer diagnosis is a process of identifying or measuring the cancer disease with a needle-free diagnosis technique. This diagnosis method comprises several techniques, including biomarkers, changes in molecular biology, genetic structure, and other imaging diagnosis techniques. Advancements in the biotechnology sector have enabled the development of non-invasive cancer diagnosis for the early detection of cancer.

Global Non-Invasive Cancer Diagnosis Market Overview

The primary factors driving the market growth are the non-invasive cancer diagnosis is a way to identify cancer problems with minimal incisions in the body. This process generally consists of various techniques such as gene structure identification, biomarkers, molecular biology modifications, and imaging techniques. The growing demand for accurate, minimally invasive diagnostics and growth in medical costs were observed across the globe as critical drivers.

In addition, increasing demand for non-invasive diagnostics increases government initiatives to improve medical infrastructure, and increased research and development projects drive market growth. However, high treatment costs and strict regulatory guidelines hamper market growth. Rapid technological advances and innovations in devices are expected to create beneficial opportunities for the market. On the other hand, the needs of untapped developing countries can challenge market growth.

Global Non-Invasive Cancer Diagnosis Market: Segmentation Analysis

The Global Non-Invasive Cancer Diagnosis Market is segmented on the basis of Technology, Instruments, And Geography.

Non-Invasive Cancer Diagnosis Market, By Technology

• Clinical Chemistry
• Immunochemistry
• Molecular Diagnostics

Based on Technology, The market is bifurcated into Clinical Chemistry, Immunochemistry, and Molecular Diagnostics. The Clinical Chemistry segment holds a large number of shares in the market because of the availability of the clinical data for several cancer indications and increasing non-invasive diagnostic technology, which is the factor that boosts the market growth.

Non-Invasive Cancer Diagnosis Market, By Instruments

• Solid Tumor
• Blood Cancer
• Lung Cancer
• Breast Cancer

Based on Instruments, The market is bifurcated into Solid Tumor, Blood Cancer, Lung Cancer, and Breast Cancer. The Breast Cancer segment holds a large number of shares in the market because of the increasing number of cases across the globe and enhancing healthcare sector, which is the factor that boosts the market growth.

Non-Invasive Cancer Diagnosis Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, The Global Non-Invasive Cancer Diagnosis Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region holds a large number of shares in the market because of the increasing healthcare expenditure and rising research and development activities in the region. At the same time, Asia-Pacific is the fastest-growing region because of the rising number of patients with an increase in awareness regarding the minimal invasive equipment in the region, which is the factor that increased the market growth.

Key Players

The "Global Non-Invasive Cancer Diagnosis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Precision Therapeutics Inc., AVIVA Biosciences Corporation, Affymetrix Inc., BIOVIEW Inc., Gen-Probe Incorporated, and many more. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NON-INVASIVE CANCER DIAGNOSIS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NON-INVASIVE CANCER DIAGNOSIS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL NON-INVASIVE CANCER DIAGNOSIS MARKET, BY TECHNOLOGY

• 5.1 Overview
• 5.2 Clinical Chemistry
• 5.3 Immunochemistry
• 5.4 Molecular Diagnostics

6 GLOBAL NON-INVASIVE CANCER DIAGNOSIS MARKET, BY INSTRUMENTS

• 6.1 Overview
• 6.2 Solid Tumor
• 6.3 Blood Cancer
• 6.4 Lung Cancer
• 6.5 Breast Cancer

7 GLOBAL NON-INVASIVE CANCER DIAGNOSIS MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East And Africa

8 GLOBAL NON-INVASIVE CANCER DIAGNOSIS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Precision Therapeutics, Inc.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 AVIVA Biosciences Corporation
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Affymetrix Inc.
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 BIOVIEW Inc.
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Gen-Probe Incorporated
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments

10 Appendix

• 10.1 Related Research